HER2 MUTANT NON-SMALL CELL LUNG CANCER

HER2 MUTANT NON-SMALL CELL LUNG CANCER was reported 11 times

These drugs are most commonly taken by patients reporting HER2 MUTANT NON-SMALL CELL LUNG CANCER:

# Drug Count
0 BEVACIZUMAB 6
1 PEMETREXED 6
2 PEMETREXED DISODIUM 6
3 CARBOPLATIN 5
4 TRASTUZUMAB 4
5 AFATINIB 3
6 DOCETAXEL 2
7 DOCETAXEL ANHYDROUS 2
8 ZONGERTINIB 2
9 CISPLATIN 1
10 ETOPOSIDE 1
11 NERATINIB 1
12 NIVOLUMAB 1
13 RAMUCIRUMAB 1